Table 2. Day 42 treatment failure rates following completion of artemether-lumefantrine (AL) therapy.
AL regimen |
||||
---|---|---|---|---|
Rate | 4 doses over 48 h | 6 doses over 60 h | 6 doses over 96 h | P |
Day 42 uncorrected rate of recurrent parasitemia, % (95% CI) | 20 (15–24)a | 13 (11–15)b | 3.9 (0–9.6) | .001 |
| ||||
Day 42 rate of recrudescence, % (95% CI) | 13.3 (9.6–17)c | 3.2 (1.8–4.6)d | 0 | <.001 |
| ||||
Day 42 rate of reinfection, % (95% CI) | 7.7 (4.8–10.6)e | 11.7 (9.6–13.7)f | 3.9 (0–9.6) | .07 |
48-h regimen vs. 60-h regimen, P = .005.
60-h regimen vs. 96-h regimen, P = .01.
48-h regimen vs. 60-h regimen, P< .001.
60-h regimen vs. 96-h regimen, P = .17.
48-h regimen vs. 60-h regimen, P = .14.
60-h regimen vs. 96-h regimen, P = .08.